John P Micha

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Radiation Therapy

Placebo Controlled

Squamous Cell Carcinoma

Top Venues

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma. Journal of gynecologic oncology 34 (2) (2022)
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma. Journal of gynecologic oncology 34 (2) (2022)
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma. Journal of gynecologic oncology 34 (2) (2022)
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma. Journal of gynecologic oncology 34 (2) (2022)
John P Micha, Mark A Rettenmaier, Randy D Bohart, Bram H Goldstein
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma. Journal of gynecologic oncology (2022)